References
- Andersson U, Erlandsson-Harris H, Yang H, Tracey KJ. HMGB1 as a DNA-binding cytokine. J Leukoc Biol 2002;72:1084–91
- Yang H, Wang H, Czura CJ, Tracey KJ. HMGB1 as a cytokine and therapeutic target. J Endotoxin Res 2002;8:469–72
- Ulloa L, Messmer D. High-mobility group box 1 (HMGB1) protein: friend and foe. Cytokine Growth Factor Rev 2006;17:189–201
- Huang WC, Tang YQ, Li L. HMGB1, a potent proinflammatory cytokine in sepsis. Cytokine 2010;51:119–26
- Tang DL, Kang R, Zeh HJ, Lotze MT. High-mobility group box 1 and cancer. Biochim Biophys Acta: Gene Regul Mech 2010;1799:131–40
- Kokkola R, Li J, Sundberg E, et al. Successful treatment of collagen-induced arthritis in mice and rats by targeting extracellular high mobility group box chromosomal protein 1 activity. Arthritis Rheum 2003;48:2052–8
- af Klint E, Grundtman C, Engstrom M, et al. Intraarticular glucocorticoid treatment reduces inflammation in synovial cell infiltrations more efficiently than in synovial blood vessels. Arthritis Rheum 2005;52:3880–9
- Kim JB, Sig Choi J, Yu YM, et al. HMGB1, a novel cytokine-like mediator linking acute neuronal death and delayed neuroinflammation in the postischemic brain. J Neurosci 2006;26:6413–21
- Mantell LL, Parrish WR, Ulloa L. Hmgb-1 as a therapeutic target for infectious and inflammatory disorders. Shock 2006;25:4–11
- Li J, Kokkola R, Tabibzadeh S, et al. Structural basis for the proinflammatory cytokine activity of high mobility group box 1. Mol Med 2003;9:37–45
- Gong W, Zheng YR, Chao F, et al. The anti-inflammatory activity of HMGB1 A box is enhanced when fused with C-terminal acidic tail. J Biomed Biotechnol 2010;2010:915234 . doi: 10.1155/2010/915234
- He ZW, Qin YH, Wang ZW, et al. HMGB1 acts in synergy with lipopolysaccharide in activating rheumatoid synovial fibroblasts via p38 MAPK and NF-kappaB signaling pathways. Mediat Inflamm 2013;2013:596716 . doi: 10.1155/2013/596716
- Yang H, Ochani M, Li J, et al. Reversing established sepsis with antagonists of endogenous high-mobility group box 1. Proc Natl Acad Sci USA 2004;101:296–301
- Yang H, Tracey KJ. Targeting HMGB1 in inflammation. Biochim Biophys Acta-Gene Regul Mech 2010;1799:149–56
- Lee S, Song H, Kim HA, et al. The box a domain of high mobility group box-1 protein as an efficient siRNA carrier with anti-inflammatory effects. J Cell Biochem 2012;113:122–31
- Gong Q, Xu JF, Yin H, et al. Protective effect of antagonist of high-mobility group box 1 on lipopolysaccharide-induced acute lung injury in mice. Scand J Immunol 2009;69:29–35
- Oh B, Lee M. Combined delivery of HMGB-1 box A peptide and S1PLyase siRNA in animal models of acute lung injury. J Control Release 2014;175:25–35
- Howard MD, Hood ED, Zern B, et al. Nanocarriers for vascular delivery of anti-inflammatory agents. Annu Rev Pharmacol Toxicol 2014;54:205–26
- Thomas JO. HMG1 and 2: architectural DNA-binding proteins. Biochem Soc Trans 2001;29:395–401
- Zayed H, Izsvak Z, Khare D, et al. The DNA-bending protein HMGB1 is a cellular cofactor of sleeping beauty transposition. Nucleic Acids Res 2003;31:2313–22
- Kim K, Han JS, Kim HA, Lee M. Expression, purification and characterization of TAT-high mobility group box-1 A peptide as a carrier of nucleic acids. Biotechnol Lett 2008;30:1331–7
- Han JS, Kim K, Lee M. A high mobility group B-1 box A peptide combined with an artery wall binding peptide targets delivery of nucleic acids to smooth muscle cells. J Cell Biochem 2009;107:163–70
- Shen Y, Peng H, Deng J, et al. High mobility group box 1 protein enhances polyethylenimine mediated gene delivery in vitro. Int J Pharm 2009;375:140–7
- Han JS, Kim HA, Lee S, Lee M. VEGF receptor binding peptide-linked high mobility box group-1 box A as a targeting gene carrier for hypoxic endothelial cells. J Cell Biochem 2010;110:1094–100
- Kim HA, Park JH, Cho SH, Lee M. Lung epithelial binding peptide-linked high mobility group box-1 A box for lung epithelial cell-specific delivery of DNA. J Drug Target 2011;19:589–96
- Lv B, Wang H, Tang Y, et al. High-mobility group box 1 protein induces tissue factor expression in vascular endothelial cells via activation of NF-kappaB and Egr-1. Thromb Haemost 2009;102:352–9
- Kim JB, Lim CM, Yu YM, Lee JK. Induction and subcellular localization of high-mobility group box-1 (HMGB1) in the postischemic rat brain. J Neurosci Res 2008;86:1125–31
- Kim K, Han JS, Park JH, et al. Expression and characterization of a recombinant high mobility group box 1 AB peptide with a 6-histidine tag for delivery of nucleic acids. Enzyme Microb Technol 2008;43:410–16
- Kim K, Han JS, Kim HA, Lee M. Expression, purification and characterization of TAT-high mobility group box-1 A peptide as a carrier of nucleic acids. Biotechnol Lett 2008;30:1331–7
- Andersson U, Erlandsson-Harris H, Yang H, Tracey KJ. HMGB1 as a DNA-binding cytokine. J Leukoc Biol 2002;72:1084–91
- Ryu DW, Kim HA, Song H, et al. Amphiphilic peptides with arginines and Vvlines for the delivery of plasmid DNA. J Cell Biochem 2011;112:1458–66
- Ryu J, Jeon P, Lee M. R3V6 amphiphilic peptide with high mobility group box 1A domain as an efficient carrier for gene delivery. Bull Korean Chem Soc 2013;34:3665–70
- Paine A, Eiz-Vesper B, Blasczyk R, Immenschuh S. Signaling to heme oxygenase-1 and its anti-inflammatory therapeutic potential. Biochem Pharmacol 2010;80:1895–903
- An L, Liu CT, Yu MJ, et al. Heme oxygenase-1 system, inflammation and ventilator-induced lung injury. Eur J Pharmacol 2012;677:1–4